2,453
Views
54
CrossRef citations to date
0
Altmetric
Review Articles

Awareness and current knowledge of Parkinson’s disease: a neurodegenerative disorder

, , &
Pages 55-93 | Received 06 Apr 2018, Accepted 04 Jun 2018, Published online: 22 Nov 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Dan-Dan Zhang, Cheng-Yun Zhang, Yu-Xin Zhang, Hai-Peng Cui, Jiao Chen, Wen-Zhi Ma & Hua Jia. (2023) G-CSF reduces loss of dopaminergic neurons by inhibiting TNF-α and IL-1β in mouse model of Parkinson’s disease. International Journal of Neuroscience 133:3, pages 278-289.
Read now
Mehmet Dumlu Aydin, Ayhan Kanat, Ahmet Hacimuftuoglu, Sevilay Ozmen, Ali Ahiskalioglu & Mehmet Nuri Kocak. (2021) A new experimental evidence that olfactory bulb lesion may be a causative factor for substantia nigra degeneration; preliminary study. International Journal of Neuroscience 131:3, pages 220-227.
Read now

Articles from other publishers (51)

Bharat Bhushan, Niraj Kumar Singh & Rajesh Singh. (2024) Traditional Chinese medicine: Its growing potential in treating neurological disorders. Pharmacological Research - Modern Chinese Medicine 11, pages 100422.
Crossref
Biplab Roy, Biswanath Bhunia, Tarun Kanti Bandyopadhyay, Shamim Ahmed Khan, Nishithendu Bikash Nandi & Pinku Chandra Nath. 2024. Handbook of Water Pollution. Handbook of Water Pollution 333 352 .
T. Ananth Kumar, M. Nidya Thirshala, P. Kanimozhi & Christo Ananth. 2024. Intelligent Technologies and Parkinson’s Disease. Intelligent Technologies and Parkinson’s Disease 164 184 .
Kacper Nijakowski, Wojciech Owecki, Jakub Jankowski & Anna Surdacka. (2024) Salivary Biomarkers for Parkinson’s Disease: A Systematic Review with Meta-Analysis. Cells 13:4, pages 340.
Crossref
Pandit Vivek Kumar Pandey & Sitanshu Sekhar Sahu. 2024. Data Science and Applications. Data Science and Applications 427 435 .
Yong-tang Song, Yan-bo Liu, Hong-bing Xiang, Anne Manyande & Zhi-gang He. (2023) The Application of Deep Brain Stimulation for Parkinson’s Disease on the Motor Pathway: A Bibliometric Analysis across 10 Years. Current Medical Science 43:6, pages 1247-1257.
Crossref
Jeremy Willekens, Pauline Mosca, Nathan Burt‐Oberecken, Edgar Laugeais, Tony Kaoma, François Bernardin, Laurent Vallar, Pauline Dimofski, Mathilde Renaud, Laetitia Lambert, Bruno Leheup, Jean‐Louis Guéant, Brigitte Leininger‐Muller & Natacha Dreumont. (2023) Cross‐Talk between miRNAs from the Dlk1‐Dio3 Locus and Histone Methylation to Protect Male Cerebellum from Methyl Donor Deficiency . Molecular Nutrition & Food Research 67:21.
Crossref
Dhivya Rajendran, Rajiv Bandhu, Sujata Gautam, Rajinder K. Dhamija & Sunita Mondal. (2023) Auditory Evoked P300 Potential in Patients With Parkinson’s Disease. Cureus.
Crossref
Hamid Mostafavi Abdolmaleky & Jin-Rong Zhou. (2023) Underlying Mechanisms of Brain Aging and Neurodegenerative Diseases as Potential Targets for Preventive or Therapeutic Strategies Using Phytochemicals. Nutrients 15:15, pages 3456.
Crossref
Shivam Kumar, Anupam Awasthi, Khadga Raj & Shamsher Singh. (2023) L-theanine attenuates LPS-induced motor deficit in experimental rat model of Parkinson’s disease: emphasis on mitochondrial activity, neuroinflammation, and neurotransmitters. Psychopharmacology 240:7, pages 1493-1508.
Crossref
Wei Qing Lim, Kie Hoon Michelle Luk, Kah Yee Lee, Nasuha Nurul, Sin Jade Loh, Zhen Xiong Yeow, Qi Xuan Wong, Qi Hao Daniel Looi, Pan Pan Chong, Chee Wun How, Sharina Hamzah & Jhi Biau Foo. (2023) Small Extracellular Vesicles’ miRNAs: Biomarkers and Therapeutics for Neurodegenerative Diseases. Pharmaceutics 15:4, pages 1216.
Crossref
Xia Zhang, Bin Chen, Yuan Xie, Yeye Hu, Zhiqiang Niu, Ziliang He, Lun Wang, Guolin Zhang, Mingkui Wang, Weicheng Hu & Fu Li. (2023) Phenolic compounds from the flowers of Rosa hugonis Hemsl. and their neuroprotective effects. Phytochemistry 208, pages 113589.
Crossref
Teresa Pardo-Moreno, Victoria García-Morales, Sami Suleiman-Martos, Antonio Rivas-Domínguez, Himan Mohamed-Mohamed, Juan José Ramos-Rodríguez, Lucía Melguizo-Rodríguez & Anabel González-Acedo. (2023) Current Treatments and New, Tentative Therapies for Parkinson’s Disease. Pharmaceutics 15:3, pages 770.
Crossref
Maria Teresa Gentile, Iolanda Camerino, Loredana Ciarmiello, Pasqualina Woodrow, Lidia Muscariello, Ida De Chiara & Severina Pacifico. (2023) Neuro-Nutraceutical Polyphenols: How Far Are We?. Antioxidants 12:3, pages 539.
Crossref
Joana Torres, Inês Costa, Andreia F. Peixoto, Renata Silva, José Manuel Sousa Lobo & Ana Catarina Silva. (2023) Intranasal Lipid Nanoparticles Containing Bioactive Compounds Obtained from Marine Sources to Manage Neurodegenerative Diseases. Pharmaceuticals 16:2, pages 311.
Crossref
Yifeng Li, Chengmei Zhang, Wei Xu, Jihua Chen, Jia Tuo, Ying Wen, Zhongxiong Huang & Rong Zeng. (2023) Serum Sirtuin1 level decreases in Parkinson's disease and vascular parkinsonism: A prospective observational study. Clinical Neurology and Neurosurgery 225, pages 107595.
Crossref
ShuJia Zuo, HaiJing Wang, Qiang Zhao, Jie Tang, Min Wang, Yu Zhang, Ming Sang, Jing Tian & Puqing Wang. (2023) High levels of Bifidobacteriaceae are associated with the pathogenesis of Parkinson’s disease. Frontiers in Integrative Neuroscience 16.
Crossref
Lianyuan Feng, Aruna Sharma, Zhenguo Wang, Dafin F. Muresanu, Z. Ryan Tian, José Vicente Lafuente, Anca D. Buzoianu, Ala Nozari, Lars Wiklund & Hari Shanker Sharma. 2023. Progress in Nanomedicine in Neurologic Diseases. Progress in Nanomedicine in Neurologic Diseases 97 138 .
Taiwo G. Olubodun-Obadun, Ismail O. Ishola & Olufunmilayo O. Adeyemi. (2022) Impact of environmental toxicants exposure on gut-brain axis in Parkinson disease. Drug Metabolism and Personalized Therapy 37:4, pages 329-336.
Crossref
Renata Terra de Oliveira, Fabiana Maria dos Santos, Alessandro Gomes Ramos, Karla Luciana Magnani Seki, Paulo de Tarso Müller & Gustavo Christofoletti. (2022) Pulmonary function and medication effect in mild-stage subjects with Parkinson's disease. Arquivos de Neuro-Psiquiatria 80:12, pages 1233-1238.
Crossref
Hong‐Xia Fan, Shuo Sheng & Feng Zhang. (2022) New hope for Parkinson's disease treatment: Targeting gut microbiota. CNS Neuroscience & Therapeutics 28:11, pages 1675-1688.
Crossref
Chenggong Jiang, Dongfang Shen, Kaiyang LiHuan Wang, Wenxu Sang & Huiping Qi. (2022) Protective Effects of Ursodeoxycholic Acid Against Oxidative Stress and Neuroinflammation Through Mitogen-Activated Protein Kinases Pathway in MPTP-Induced Parkinson Disease. Clinical Neuropharmacology 45:6, pages 168-174.
Crossref
Erin John Rieger de Almeida, Hélio Jungkenn Ibrahim, Maria Rosa Chitolina Schetinger, Cinthia Melazzo de Andrade & Andréia Machado Cardoso. (2022) Modulation of Inflammatory Mediators and Microglial Activation Through Physical Exercise in Alzheimer’s and Parkinson's Diseases. Neurochemical Research 47:11, pages 3221-3240.
Crossref
Jessica Valencia, Marta Ferreira, J. Francisco Merino-Torres, Antonio Marcilla & Jose M. Soriano. (2022) The Potential Roles of Extracellular Vesicles as Biomarkers for Parkinson’s Disease: A Systematic Review. International Journal of Molecular Sciences 23:19, pages 11508.
Crossref
Zhiran Kang, Hua Xing, Qiang Lin, Fanchao Meng & Li Gong. (2022) Effectiveness of therapeutic massage for improving motor symptoms in Parkinson's disease: A systematic review and meta-analysis. Frontiers in Neurology 13.
Crossref
Xi Yin, Miao Wang, Wei Wang, Tong Chen, Ge Song, Yixuan Niu, Ziying Jiang, Zhongbao Gao & Zhenfu Wang. (2022) Identification of Potential miRNA-mRNA Regulatory Network Contributing to Parkinson’s Disease. Parkinson's Disease 2022, pages 1-12.
Crossref
Francisco Gerson A. de Meneses, Ariel Soares Teles, Monara Nunes, Daniel da Silva Farias & Silmar Teixeira. (2022) Neural Networks to Recognize Patterns in Topographic Images of Cortical Electrical Activity of Patients with Neurological Diseases. Brain Topography 35:4, pages 464-480.
Crossref
Taiwo G. Olubodun-Obadun, Ismail O. Ishola & Olufunmilayo O. Adeyemi. (2022) Potentials of autophagy enhancing natural products in the treatment of Parkinson disease. Drug Metabolism and Personalized Therapy 37:2, pages 99-110.
Crossref
Binglong Li, Di An & Shasha Zhu. (2022) PBX1 attenuates 6-OHDA-induced oxidative stress and apoptosis and affects PINK1/PARKIN expression in dopaminergic neurons via FOXA1. Cytotechnology 74:2, pages 217-229.
Crossref
Jinlong Wu, Hui Zhang, Ziyan Chen, Ruijia Fu, Hao Yang, Hongfa Zeng & Zhanbing Ren. (2022) Benefits of Virtual Reality Balance Training for Patients With Parkinson Disease: Systematic Review, Meta-analysis, and Meta-Regression of a Randomized Controlled Trial. JMIR Serious Games 10:1, pages e30882.
Crossref
Tien-Wei Hsu, Che-Sheng Chu, Shih-Jen Tsai, Chih-Ming Cheng, Tung-Ping Su, Tzeng-Ji Chen, Ya-Mei Bai, Chih-Sung Liang & Mu-Hong Chen. (2022) Dengue Virus Infection and Risk of Parkinson’s Disease: A Nationwide Longitudinal Study. Journal of Parkinson's Disease 12:2, pages 679-687.
Crossref
Jingsheng Yang, Quanhao Guo, Xianwei Zou, Meng Wang, Yanxia Wen, Xiaqing Chen, Xiechuan Weng & Fan Xu. (2021) Correlation between head tremble and the severity of Parkinson’s disease. CNS Neuroscience & Therapeutics 28:2, pages 218-225.
Crossref
Anastasiia Dmytrivna Shkodina, Shing Cheng Tan, Mohammad Mehedi Hasan, Mai Abdelgawad, Hitesh Chopra, Muhammad Bilal, Dmytro Ivanovych Boiko, Kateryna Anatoliivna Tarianyk & Athanasios Alexiou. (2022) Roles of clock genes in the pathogenesis of Parkinson's disease. Ageing Research Reviews 74, pages 101554.
Crossref
Rajalakshmi Rajendran, Roshni Pushpa Ragavan, Abdullah G. Al-Sehemi, Md. Sahab Uddin, Lotfi Aleya & Bijo Mathew. (2022) Current understandings and perspectives of petroleum hydrocarbons in Alzheimer’s disease and Parkinson’s disease: a global concern. Environmental Science and Pollution Research 29:8, pages 10928-10949.
Crossref
Xiao-xian Li & Feng Zhang. (2021) Targeting TREM2 for Parkinson’s Disease: Where to Go?. Frontiers in Immunology 12.
Crossref
Shige Qi, Peng Yin, Linhong Wang, Ming Qu, Ge Lin Kan, Han Zhang, Qingjun Zhang, Yize Xiao, Ying Deng, Zhong Dong, Yan Shi, Jun Meng, Piu Chan & Zhihui Wang. (2021) Prevalence of Parkinson's Disease: A Community‐Based Study in China. Movement Disorders 36:12, pages 2940-2944.
Crossref
Zornitsa Mitkova, Maria Kamusheva, Dobrinka Kalpachka, Desislava Ignatova, Konstantin Tachkov & Guenka Petrova. (2022) Review of Medicine Utilization for Parkinson's Disease Management: The Bulgarian Perspective. Journal of Public Health Research 10:4, pages jphr.2021.2396.
Crossref
Fatima Jamali, Mayis Aldughmi, Mohammad W Khasawneh, Said Dahbour, Alaa A Salameh & Abdalla Awidi. (2021) A New Tool for Safety Evaluation and a Combination of Measures for Efficacy Assessment of Cotransplanting Human Allogenic Neuronal Stem Cells and Mesenchymal Stem Cells for the Treatment of Parkinson Disease: Protocol for an Interventional Study. JMIR Research Protocols 10:10, pages e29695.
Crossref
Liu-Cheng Li, Jie Chen, Xiao-Bin Zhu, Meng Guo, Qin Chen, Hong-Mei Fang & Lian-Di Kan. (2021) Trends of complications in patients with Parkinson’s disease in seven major cities of China from 2016 to 2019. International Clinical Psychopharmacology 36:5, pages 274-278.
Crossref
Mirza Muntasir Nishat, Tasnimul Hasan, Sarker Md. Nasrullah, Fahim Faisal, Md. Asfi-Ar-Raihan Asif & Md. Ashraful Hoque. (2021) Detection of Parkinson's Disease by Employing Boosting Algorithms. Detection of Parkinson's Disease by Employing Boosting Algorithms.
Junli Li, Haiyan Liao, Tianyu Wang, Yuheng Zi, Lin Zhang, Min Wang, Zhenni Mao, ChenDie Song, Fan Zhou, Qin Shen, Sainan Cai & Changlian Tan. (2021) Alterations of Regional Homogeneity in the Mild and Moderate Stages of Parkinson’s Disease. Frontiers in Aging Neuroscience 13.
Crossref
Min Zhang, Wei Liu, Qingan Zhang & Hongfeng Hu. (2021) miR-101-3p Contributes to α-Synuclein Aggregation in Neural Cells through the miR-101-3p/SKP1/PLK2 Pathway. Journal of Healthcare Engineering 2021, pages 1-8.
Crossref
琳 周. (2021) High-Frequency Repetitive Transcranial Magnetic Stimulation on the Bilateraldorsolateral Prefrontal Cortex Improves Walking Function in Parkinson’s Disease. Advances in Clinical Medicine 11:08, pages 3784-3791.
Crossref
Jatinder Pal Singh, Balwinder Singh & Amritpal Kaur. 2021. Nutrition, Food and Diet in Ageing and Longevity. Nutrition, Food and Diet in Ageing and Longevity 221 238 .
Rasool Haddadi, Zahra Shahidi & Shahla Eyvari-Brooshghalan. (2020) Silymarin and neurodegenerative diseases: Therapeutic potential and basic molecular mechanisms. Phytomedicine 79, pages 153320.
Crossref
Rita de Cassia Niz Malko, Marina Wolff Branco, Adriano Zanardi da Silva, Bruna Yamaguchi & Vera Lúcia Israel. (2020) Análise de desvios posturais em indivíduos com Doença de Parkinson avaliados pela fotogrametria. Revista Neurociências 28, pages 1-14.
Crossref
Carla Ferreira, Catarina Almeida, Sandra Tenreiro & Alexandre Quintas. (2020) Neuroprotection or Neurotoxicity of Illicit Drugs on Parkinson’s Disease. Life 10:6, pages 86.
Crossref
Upasana Ganguly, Anindita Banerjee, Sankha Shubhra Chakrabarti, Upinder Kaur, Oishimaya Sen, Roberto Cappai & Sasanka Chakrabarti. (2020) Interaction of α-synuclein and Parkin in iron toxicity on SH-SY5Y cells: implications in the pathogenesis of Parkinson's disease. Biochemical Journal 477:6, pages 1109-1122.
Crossref
Svetlana Tomic. 2020. Genetics, Neurology, Behavior, and Diet in Parkinson's Disease. Genetics, Neurology, Behavior, and Diet in Parkinson's Disease 597 608 .
Ewa Siucinska. (2019) Γ-Aminobutyric acid in adult brain: an update. Behavioural Brain Research 376, pages 112224.
Crossref
Feng Zhu, Chuling Li, Jianfeng Gong, Weiming Zhu, Lili Gu & Ning Li. (2019) The risk of Parkinson’s disease in inflammatory bowel disease: A systematic review and meta-analysis. Digestive and Liver Disease 51:1, pages 38-42.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.